Genetic risk converges on regulatory networks mediating early type 2 diabetesJohn T. Walker, Marcela Briššová, Yasminye D. Pettway et al.|Nature|2023Cited by 71
Dapagliflozin Does Not Directly Affect Human α or β CellsChunhua Dai, Alvin C. Powers, John T. Walker et al.|Endocrinology|2020Cited by 15
RFX6-mediated dysregulation defines human β cell dysfunction in early type 2 diabetesJohn T. Walker, Marcela Briššová, Diane C. Saunders et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 9